Application 214439
- Type
- NDA
- Sponsor
- CMP DEV LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NORLIQVA | AMLODIPINE | SOLUTION; ORAL | 1MG/1ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214439-001 | NORLIQVA | AMLODIPINE BESYLATE | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N214439-001 | 11253474 | 2041-02-24 | U-3309 | Drug product | 2022-02-28 |
| N214439-001 | 11253474 | 2041-02-24 | U-3310 | Drug product | 2022-02-28 |
| N214439-001 | 11253474 | 2041-02-24 | U-3311 | Drug product | 2022-02-28 |
| N214439-001 | 11458095 | 2041-02-24 | U-3309 | Drug product | 2022-10-05 |
| N214439-001 | 11458095 | 2041-02-24 | U-3310 | Drug product | 2022-10-05 |
| N214439-001 | 11458095 | 2041-02-24 | U-3311 | Drug product | 2022-10-05 |
| N214439-001 | 11723866 | 2041-02-24 | U-3309 | Drug product | 2023-08-18 |
| N214439-001 | 11723866 | 2041-02-24 | U-3310 | Drug product | 2023-08-18 |
| N214439-001 | 11723866 | 2041-02-24 | U-3311 | Drug product | 2023-08-18 |
| N214439-001 | 12005141 | 2041-02-24 | U-3309 | Drug product | 2024-06-28 |
| N214439-001 | 12005141 | 2041-02-24 | U-3310 | Drug product | 2024-06-28 |
| N214439-001 | 12005141 | 2041-02-24 | U-3311 | Drug product | 2024-06-28 |
| N214439-001 | 12226528 | 2041-02-24 | U-3309 | Drug product | 2025-02-27 |
| N214439-001 | 12226528 | 2041-02-24 | U-3310 | Drug product | 2025-02-27 |
| N214439-001 | 12226528 | 2041-02-24 | U-3311 | Drug product | 2025-02-27 |
| N214439-001 | 12440441 | 2041-02-24 | U-3309 | Drug product | 2025-10-23 |
| N214439-001 | 12440441 | 2041-02-24 | U-3310 | Drug product | 2025-10-23 |
| N214439-001 | 12440441 | 2041-02-24 | U-3311 | Drug product | 2025-10-23 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 4b0b4de00fa7… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N214439-001 | NORLIQVA | EQ 1MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2022-02-24 | a50c72e98297… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11253474 | 2041-02-24 | U-3309 | Drug product | 2022-02-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11253474 | 2041-02-24 | U-3310 | Drug product | 2022-02-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11253474 | 2041-02-24 | U-3311 | Drug product | 2022-02-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11458095 | 2041-02-24 | U-3309 | Drug product | 2022-10-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11458095 | 2041-02-24 | U-3310 | Drug product | 2022-10-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11458095 | 2041-02-24 | U-3311 | Drug product | 2022-10-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11723866 | 2041-02-24 | U-3309 | Drug product | 2023-08-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11723866 | 2041-02-24 | U-3311 | Drug product | 2023-08-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 11723866 | 2041-02-24 | U-3310 | Drug product | 2023-08-18 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12005141 | 2041-02-24 | U-3311 | Drug product | 2024-06-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12005141 | 2041-02-24 | U-3309 | Drug product | 2024-06-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12005141 | 2041-02-24 | U-3310 | Drug product | 2024-06-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12226528 | 2041-02-24 | U-3309 | Drug product | 2025-02-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12226528 | 2041-02-24 | U-3310 | Drug product | 2025-02-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12226528 | 2041-02-24 | U-3311 | Drug product | 2025-02-27 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12440441 | 2041-02-24 | U-3309 | Drug product | 2025-10-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12440441 | 2041-02-24 | U-3311 | Drug product | 2025-10-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214439-001 | 12440441 | 2041-02-24 | U-3310 | Drug product | 2025-10-23 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11253474 | 2041-02-24 | U-3309 | Drug product | 2022-02-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11253474 | 2041-02-24 | U-3310 | Drug product | 2022-02-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11253474 | 2041-02-24 | U-3311 | Drug product | 2022-02-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11458095 | 2041-02-24 | U-3309 | Drug product | 2022-10-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11458095 | 2041-02-24 | U-3310 | Drug product | 2022-10-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11458095 | 2041-02-24 | U-3311 | Drug product | 2022-10-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11723866 | 2041-02-24 | U-3309 | Drug product | 2023-08-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11723866 | 2041-02-24 | U-3311 | Drug product | 2023-08-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 11723866 | 2041-02-24 | U-3310 | Drug product | 2023-08-18 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12005141 | 2041-02-24 | U-3311 | Drug product | 2024-06-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12005141 | 2041-02-24 | U-3309 | Drug product | 2024-06-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12005141 | 2041-02-24 | U-3310 | Drug product | 2024-06-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12226528 | 2041-02-24 | U-3309 | Drug product | 2025-02-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12226528 | 2041-02-24 | U-3310 | Drug product | 2025-02-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12226528 | 2041-02-24 | U-3311 | Drug product | 2025-02-27 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12440441 | 2041-02-24 | U-3309 | Drug product | 2025-10-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12440441 | 2041-02-24 | U-3311 | Drug product | 2025-10-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214439-001 | 12440441 | 2041-02-24 | U-3310 | Drug product | 2025-10-23 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N214439-001 | 11253474 | 2041-02-24 | U-3309 | Drug product | 2022-02-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214439-001 | 11253474 | 2041-02-24 | U-3310 | Drug product | 2022-02-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214439-001 | 11253474 | 2041-02-24 | U-3311 | Drug product | 2022-02-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214439-001 | 11458095 | 2041-02-24 | U-3309 | Drug product | 2022-10-05 | 6a471c1ec25d… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NORLIQVA | AMLODIPINE | CMP Pharma, Inc. | 614d974f-51c7-4b18-8171-39eb6e8d4c03 | 2026-02-16 | Warnings, Adverse reactions | 214439 NDA214439 |
| NORLIQVA | AMLODIPINE | CMP Pharma, Inc. | c1730a51-4383-4c61-a9a1-7e1326bd0abe | 2022-02-28 | Warnings, Adverse reactions | 214439 NDA214439 46287-035 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 46287-035 | NORLIQVA | amlodipine | CMP Pharma, Inc. | NDA | Current |